16697724

Source:http://linkedlifedata.com/resource/pubmed/id/16697724

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001948, umls-concept:C0015737, umls-concept:C0087111, umls-concept:C0220847, umls-concept:C1096776, umls-concept:C1274040
pubmed:issue	6
pubmed:dateCreated	2006-5-15
pubmed:abstractText	Patients with hepatitis C virus (HCV) infection who use alcohol have been excluded from clinical trials; therefore, outcomes with antiviral therapy are unknown. The aim of the study was to determine the impact of alcohol use on HCV treatment outcomes.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16697724-16697753
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374630
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0016-5085
pubmed:author	pubmed-author:AnandBhupinder SBS, pubmed-author:BiniEdmund JEJ, pubmed-author:CurrieSueS, pubmed-author:DieperinkEricE, pubmed-author:HoSamuel BSB, pubmed-author:ShenHuiH, pubmed-author:VA-HCV-001 Study Group, pubmed-author:WrightTeresaT
pubmed:issnType	Print
pubmed:volume	130
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1607-16
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16697724-Aged, pubmed-meshheading:16697724-Alcohol Drinking, pubmed-meshheading:16697724-Antiviral Agents, pubmed-meshheading:16697724-Case-Control Studies, pubmed-meshheading:16697724-Dose-Response Relationship, Drug, pubmed-meshheading:16697724-Drug Administration Schedule, pubmed-meshheading:16697724-Female, pubmed-meshheading:16697724-Follow-Up Studies, pubmed-meshheading:16697724-Hepatitis C, Chronic, pubmed-meshheading:16697724-Humans, pubmed-meshheading:16697724-Interferon-alpha, pubmed-meshheading:16697724-Liver Function Tests, pubmed-meshheading:16697724-Male, pubmed-meshheading:16697724-Middle Aged, pubmed-meshheading:16697724-Patient Selection, pubmed-meshheading:16697724-Probability, pubmed-meshheading:16697724-Prospective Studies, pubmed-meshheading:16697724-Recombinant Proteins, pubmed-meshheading:16697724-Reference Values, pubmed-meshheading:16697724-Ribavirin, pubmed-meshheading:16697724-Risk Assessment, pubmed-meshheading:16697724-Severity of Illness Index, pubmed-meshheading:16697724-Statistics, Nonparametric, pubmed-meshheading:16697724-Survival Rate, pubmed-meshheading:16697724-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
pubmed:affiliation	Department of Medicine, Michael E. DeBakey VA Medical Center, Houston, Texas, USA. ana0@flash.net
pubmed:publicationType	Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Multicenter Study